Search tips
Search criteria 


Logo of aidsrestherBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleAIDS Research and Therapy
AIDS Res Ther. 2012; 9: 23.
Published online Aug 1, 2012. doi:  10.1186/1742-6405-9-23
PMCID: PMC3472320
Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure
Alain Lafeuillade,corresponding author1 Vicente Soriano,2 Marie Suzan-Monti,3,4,5 Mario Stevenson,6 Jacques Izopet,7 and Hans-Jürgen Stellbrink8
1Department of Infectious Diseases, General Hospital, Toulon, France
2Department of Infectious Diseases Hospital Carlos III, Madrid, Spain
3INSERM, U912 (SESSTIM), Marseille, France
4Aix Marseille Université, IRD, UMR_S912, Marseille, France
5ORS PACA, Observatoire Régional de la Santé Provence Alpes Côte d'Azur, Marseille, France
6Miller MedicalSchool, University of Miami, Miami, FL, USA
7Laboratoire de Virologie, Institut Fédératif de Biologie, Hôpital Purpan, Toulouse, France
8Infektions Medizinisches Centrum Hamburg Study Center, Hamburg, Germany
corresponding authorCorresponding author.
Alain Lafeuillade: alain.lafeuillade/at/; Vicente Soriano: vsoriano/at/; Marie Suzan-Monti: marie.suzan/at/; Mario Stevenson: mstevenson/at/; Jacques Izopet: izopet.j/at/; Hans-Jürgen Stellbrink: stellbrink/at/
Received July 6, 2012; Accepted July 19, 2012.
The 2012 International Symposium on HIV and Emerging Infectious Diseases (ISHEID) provided a forum for investigators to hear the latest research developments in the clinical management of HIV and HCV infections as well as HIV-1 reservoirs and cure research. Combined anti-retroviral therapy (c-ART) has had a profound impact on the disease prognosis of individuals living with HIV-1 infection. However, although these anti-retroviral regimens are able to reduce plasma viremia to below the limits of detection for sustained periods of time, there is a rapid recrudescence in plasma viremia if treatment is interrupted. Therefore, despite this potent anti-retroviral suppression, HIV-1 is able to persist within the infected individual. The main 2012 ISHEID theme was, hence “searching for an HIV cure”. In this report we not only give details on this main topic of the 2012 ISHEID but also summarize what has been discussed in the areas of HIV epidemiology, access to care, antiretroviral therapy management and recent progress in the therapy of HCV infection in patients with HIV.
Keywords: HIV pandemic, HIV cure, HIV reservoirs, Antiretroviral therapy, HCV coinfection, Access to care, New anti-HCV drugs
Articles from AIDS Research and Therapy are provided here courtesy of
BioMed Central